Navigation Links
Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients

doses, and treatment regimens. Each of the currently ongoing and planned studies is aimed at gaining wider experience for this novel treatment approach and to bring us closer towards a causal and disease-modifying therapy for a broad range of allergic diseases."

Cytos Biotechnology will host a conference call and Q&A session today, Tuesday, March 13, 2007 at 9.30 am CET to discuss the study findings.

To access the conference call, please dial the following numbers:

Europe +41 91 610 56 00

U.S. +1 866 291 41 66

U.K. +44 207 107 06 11

The conference call will be held in English and will also be accessible by webcast on the internet. You may follow the call live or have it replayed later on demand. To access the webcast and the presentation, please follow the link provided on our homepage www.cytos.com. The presentation slides will be available for download 30 minutes prior to the conference call.

About the phase IIa study and the analysis

The randomized, double-blind and placebo-controlled phase IIa study included 40 male and female patients aged 18 to 65 and suffering from mild to moderate seasonal allergic rhinitis due to grass pollen allergy. Upon entry into the study, the allergic status of the individual participants was recorded by the conjunctival provocation test, a commonly used allergy test. The study participants were randomized into 4 treatment groups with 10 patients each and received 6 weekly injections of either i) 300 ?g CYT003-QbG10, ii) 300 ?g CYT003-QbG10 plus Alum, iii) placebo (PBS or Alum), or iv) 300 ?g CYT003-QbG10 plus grass pollen extract (this last group was handled exploratory and open-label). Two weeks after the last dose, the allergic status of the patients was again assessed by the conjunctival provocation test. All 40 patients were included into the analysis.

Ab
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:8/27/2014)... Calif. , Aug. 27, 2014  AcelRx Pharmaceuticals, ... company focused on the development and commercialization of innovative ... today announced that senior management will be participating at ... at the Morgan Stanley Global Healthcare Conference.  Details of ... Healthcare One on One Conference Date: Wednesday September 3 ...
(Date:8/26/2014)... Intelomed is pleased to announce that ... as the Vice President of Clinical Affairs. With over ... device industry, Kay,s experience in taking medical technology and ... to global expansion, is a valuable addition to the ... on our team, and I am confident her focused ...
(Date:8/26/2014)... NEW YORK , Aug. 26, 2014 ... market research report is available in its ... Market Outlook to 2020 ... & Gastroscopes Market Outlook to 2020 ... & Gastroscopes Market Outlook to 2020", provides ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 2AcelRx Pharmaceuticals to Participate in Two Upcoming Investor Events 3Mary Kay Deck joins Intelomed as Vice President of Clinical Affairs 2Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 2Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 3Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 4Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 5
... March 1, 2011 Heska Corporation (Nasdaq: ... and specialty products to veterinarians, today announced the addition ... in-clinic blood analyzers. (Logo:   http://photos.prnewswire.com/prnh/20000622/HESKALOGO ) ... analyzer is used to measure lactate, and is ideal ...
... successful contract packaging and re-packaging companies in the ... new, single-source industry leader called Aphena Pharma ... corporation based on a strategic alliance between Celeste ... Packaging; all long-term specialized leaders in the contract ...
Cached Medicine Technology:Heska Introduces New Lactate Meter Analyzer 2Merger of Four Pharmaceutical Companies Announced 2
(Date:8/27/2014)... Ellen V. Krieger, DDS released a new ... video is meant to describe the business and industry best ... over 28 years of cosmetic and family dentistry experience, Dr ... patients feel welcomed and cared for. , Dr. Krieger has ... years, building a solid reputation of offering bright, friendly service ...
(Date:8/27/2014)... Los Angeles, CA (PRWEB) August 27, 2014 ... Media Meetup event in collaboration with Diabetes Community Advocacy ... on October 24-25, 2014 at Embassy Suites LAX ... “DiabetesSisters’ Social Media Meetup featuring DSMA Live”, an event ... on Friday evening, October 24th. , Interactive in many ...
(Date:8/27/2014)... NJ (PRWEB) August 27, 2014 ... management, governance, and compliance software solutions for next-generation ... made Inc. magazine’s Inc. 500|5000, an exclusive ranking ... fifth consecutive year. AvePoint joins brands such as ... the 2014 edition. , This underscores continued ...
(Date:8/27/2014)... one of the most loved online bamboo product suppliers; the ... Recently, it has announced its new selection of bamboo ... to offer one-stop shopping solutions for people who want to ... is providing big discounts for all the brand new bamboo ... discounted price (up to 30% off) before the deadline on ...
(Date:8/27/2014)... CA (PRWEB) August 27, 2014 AttorneyOne.com, ... regarding all the latest information from the FDA on ... announced on August 1, that Organic Raw Carob Powder ... is recalled due to possible contamination with ... people with weakened immune systems. In healthy people it ...
Breaking Medicine News(10 mins):Health News:Ellen V. Krieger, DDS of McLean, Virginia Announces New Video Describing Industry Best Practices 2Health News:DiabetesSisters and Diabetes Community Advocacy Foundation Join Forces to Bring Together People with Diabetes in Los Angeles 2Health News:DiabetesSisters and Diabetes Community Advocacy Foundation Join Forces to Bring Together People with Diabetes in Los Angeles 3Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 2Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 3Health News:Brand New Bamboo Plywoods Now Offered At BambooIndustry.com 2Health News:Organic Raw Carob Powder by Sunburst SuperFoods Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2
... Daiichi Sankyo, Inc. and Eli Lilly and ... the U.S. Food and Drug Administration (FDA) approved Effient(TM) ... (including stent thrombosis) in patients with acute coronary syndromes ... percutaneous coronary intervention (PCI). PCI usually includes the ...
... tip the scales toward more health risks, researcher says , FRIDAY, ... night, make you snap at your spouse and children, and make ... can also make you gain weight -- especially if you,re overweight ... people out, and stress has been linked to a number of ...
... a bi-national team of global health researchers at the University ... among male clients of female sex workers in Tijuana, has ... unprotected sex. They also reported a high prevalence of ... is necessary to prevent the spread of HIV and other ...
... ecological study of its kind in the world, a Wake ... finding that groundwater and airborne manganese in North Carolina correlates ... ... County in North Carolina: An Ecological Study," was published online ...
... July 10 Compirion Healthcare Solutions, a whole-hospital process improvement ... to help educate hospital executives, managers and clinicians in strategies for ... be found at www.compirion.com/webinars along with times, ... entitled Achieving Early AM Hospital Discharges: ...
... , WASHINGTON, July 10 The Department of Veterans ... design and build a free-standing spinal cord injury center ... The contract was awarded to the C3T Construction Company ... building will have a connecting tunnel, providing access to ...
Cached Medicine News:Health News:Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM) 2Health News:Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM) 3Health News:Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM) 4Health News:Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM) 5Health News:Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM) 6Health News:Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM) 7Health News:Job Stress, Economy Weighing on Americans 2Health News:Risky sexual behavior among male clients of Tijuana sex workers heightens risk of HIV transmission 2Health News:Environmental manganese good in trace amounts but can correlate to cancer rates 2Health News:Compirion Healthcare Sponsors Free Webinar On Achieving Early Hospital Discharges 2Health News:Compirion Healthcare Sponsors Free Webinar On Achieving Early Hospital Discharges 3
... Bio-Modular total shoulder system is ... use in both hemiarthroplasty and ... Modularity in combination with a ... component options provide the surgeon ...
...
...
... Knee employs titanium alloy plasma spray ... fixation surface. Biomet's ArCom processed polyethylene ... proven bearing material. The Maxim Knee ... Modular tibial components offer excellent sizing ...
Medicine Products: